BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28983080)

  • 1. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
    Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
    Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.
    Cairat M; Rinaldi S; Navionis AS; Romieu I; Biessy C; Viallon V; Olsen A; Tjønneland A; Fournier A; Severi G; Kvaskoff M; Fortner RT; Kaaks R; Aleksandrova K; Schulze MB; Masala G; Tumino R; Sieri S; Grasso C; Mattiello A; Gram IT; Olsen KS; Agudo A; Etxezarreta PA; Sánchez MJ; Santiuste C; Barricarte A; Monninkhof E; Hiensch AE; Muller D; Merritt MA; Travis RC; Weiderpass E; Gunter MJ; Dossus L
    BMC Med; 2022 Apr; 20(1):118. PubMed ID: 35430795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased TNF α, IL-6 and ErbB2 mRNA expression in peripheral blood leukocytes from breast cancer patients.
    Alokail MS; Al-Daghri NM; Mohammed AK; Vanhoutte P; Alenad A
    Med Oncol; 2014 Aug; 31(8):38. PubMed ID: 24961464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
    Gross AL; Newschaffer CJ; Hoffman-Bolton J; Rifai N; Visvanathan K
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1319-24. PubMed ID: 23651666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
    Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin use, adipokine profiles and breast cancer prognosis.
    Wintrob ZA; Hammel JP; Khoury T; Nimako GK; Fu HW; Fayazi ZS; Gaile DP; Forrest A; Ceacareanu AC
    Cytokine; 2017 Jan; 89():45-61. PubMed ID: 27914795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
    Simone V; D'Avenia M; Argentiero A; Felici C; Rizzo FM; De Pergola G; Silvestris F
    Oncologist; 2016 Apr; 21(4):404-17. PubMed ID: 26865587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of adiponectin gene polymorphism and serum level in postmenopausal obese patients with breast cancer.
    Mahmoud EH; Fawzy A; El-Din WM; Shafik NF
    J Cancer Res Ther; 2020; 16(6):1269-1273. PubMed ID: 33342783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk.
    Teras LR; Goodman M; Patel AV; Bouzyk M; Tang W; Diver WR; Feigelson HS
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2553-7. PubMed ID: 19723917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperresistinemia is associated with postmenopausal breast cancer.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
    Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
    Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
    Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer.
    Peña-Cano MI; Saucedo R; Morales-Avila E; Valencia J; Zavala-Moha JA; López A
    Gynecol Obstet Invest; 2019; 84(4):369-377. PubMed ID: 30650411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.
    Hong T; Liu A; Cai D; Zhang Y; Hua D; Hang X; Wu X
    Cancer Invest; 2013 May; 31(4):279-85. PubMed ID: 23627410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.
    Lee CG; Carr MC; Murdoch SJ; Mitchell E; Woods NF; Wener MH; Chandler WL; Boyko EJ; Brunzell JD
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1104-10. PubMed ID: 19126626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.